Your browser doesn't support javascript.
loading
Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging.
Wall, Matthew A; Shaffer, Travis M; Harmsen, Stefan; Tschaharganeh, Darjus-Felix; Huang, Chun-Hao; Lowe, Scott W; Drain, Charles Michael; Kircher, Moritz F.
Afiliação
  • Wall MA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shaffer TM; Department of Chemistry, Hunter College and the Graduate Center, City University of New York, New York, NY, USA.
  • Harmsen S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tschaharganeh DF; Department of Chemistry, Hunter College and the Graduate Center, City University of New York, New York, NY, USA.
  • Huang CH; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drain CM; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kircher MF; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Theranostics ; 7(12): 3068-3077, 2017.
Article em En | MEDLINE | ID: mdl-28839464
ABSTRACT
A single contrast agent that offers whole-body non-invasive imaging along with the superior sensitivity and spatial resolution of surface-enhanced resonance Raman scattering (SERRS) imaging would allow both pre-operative mapping and intraoperative imaging and thus be highly desirable. We hypothesized that labeling our recently reported ultrabright SERRS nanoparticles with a suitable radiotracer would enable pre-operative identification of regions of interest with whole body imaging that can be rapidly corroborated with a Raman imaging device or handheld Raman scanner in order to provide high precision guidance during surgical procedures. Here we present a straightforward new method that produces radiolabeled SERRS nanoparticles for combined positron emission tomography (PET)-SERRS tumor imaging without requiring the attachment of molecular chelators. We demonstrate the utility of these PET-SERRS nanoparticles in several proof-of-concept studies including lymph node (LN) tracking, intraoperative guidance for LN resection, and cancer imaging after intravenous injection. We anticipate that the radiolabeling method presented herein can be applied generally to nanoparticle substrates of various materials by first coating them with a silica shell and then applying the chelator-free protocol.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Espectral Raman / Carcinoma Hepatocelular / Meios de Contraste / Tomografia por Emissão de Pósitrons / Imagem Corporal Total / Nanopartículas / Marcação por Isótopo Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Espectral Raman / Carcinoma Hepatocelular / Meios de Contraste / Tomografia por Emissão de Pósitrons / Imagem Corporal Total / Nanopartículas / Marcação por Isótopo Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article